HORMAD2-AS1: A Potential Drug Target and Biomarker (G101929664)

Target Name: HORMAD2-AS1

NCBI ID: G101929664

HORMAD2-AS1

Other Name(s): MTMR3-AS1 | HORMAD2 and MTMR3 antisense RNA 1

HORMAD2-AS1: A Potential Drug Target and Biomarker

Hormad2-AS1, also known as MTMR3-AS1, is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. Its unique structure and expression pattern have led to its potential as a drug target and biomarker.

The Hormad2-AS1 protein is composed of 21 kDa?±2 and 19 kDa?? subunits. The ?±2 subunit consists of a 166 amino acid residue that is predominantly hydrophobic, while the ?? subunit consists of a 126 amino acid residue that is predominantly hydrophilic. The ?? subunit contains a unique N-terminal region that is rich in electrostatic potential and is involved in protein-protein interactions.

Hormad2-AS1 is a key regulator of cell proliferation and survival. It has been shown to play a role in the regulation of cell growth, differentiation, and apoptosis. In addition, Hormad2-AS1 has also been shown to play a role in the regulation of cell-cell adhesion, migration, and invasion.

The unique structure and expression pattern of Hormad2-AS1 have led to its potential as a drug target. Its hydrophobic ?±2 subunit has been shown to be a potential target for small molecules that can modulate its activity. Additionally, its rich N-terminal region has been shown to be involved in protein-protein interactions, which could provide a means of targeting it with antibodies or other therapeutic agents.

Hormad2-AS1 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its expression has been shown to be elevated in various tissues of cancer, including breast, ovarian, and colorectal cancer. This suggests that Hormad2-AS1 may be a useful biomarker for the diagnosis and treatment of these diseases.

In addition to its potential as a drug target and biomarker, Hormad2-AS1 is also of interest due to its unique expression pattern. Its expression is highly dependent on theNotch signaling pathway, which is a well-established regulator of stem cell proliferation and differentiation. This suggests that Hormad2-AS1 may be a useful target for drugs that are able to modulate theNotch signaling pathway.

In conclusion, Hormad2-AS1 is a protein that has unique structure and expression pattern, and its potential as a drug target and biomarker make it an attractive target for further investigation. Further studies are needed to determine the full function of Hormad2-AS1 and its potential as a therapeutic agent.

Protein Name: HORMAD2 And MTMR3 Antisense RNA 1

The "HORMAD2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HORMAD2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets